NCT01606072View on ClinicalTrials.gov

Perioperative Use of Desmopressin (DDAVP) in Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

February 28, 2015

Study Completion Date

July 31, 2015

Conditions
Breast Cancer
Interventions
DRUG

Desmopressin

20 patients in 5 groups 4 each, advancing progressively to each dose level.

Trial Locations (1)

Unknown

Hospital Interzonal General De Agudos EvaPeron, Buenos Aires

Sponsors
All Listed Sponsors
lead

Laboratorio Elea Phoenix S.A.

INDUSTRY